N. Henderson

A molecular analysis of the telomeric end of the major histocompatibility complex. DNA typing of HLA-A3 subtypes and -B7.

M. Worwood, A. Burnett, D. Wilson, 1995, Human immunology.

Human major histocompatibility complex contains several leukemia susceptibility genes.

M. Worwood, K. Mills, D. Gaffney, 1994, Leukemia & lymphoma.

MHC class III polymorphisms in selection of donors for BMT.

K. Mills, E. Chalmers, A. Burnett, 1993, Bone marrow transplantation.

Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia.

G. Owen, K. Mills, A. Burnett, 1995, Leukemia.

Homozygous MHC genotypes and longevity.

K. Mills, D. Gaffney, A. Burnett, 1994, Human heredity.

Antibody‐mediated rejection despite inhibition of terminal complement

M. Stegall, P. Dean, L. Cornell, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Importance of methodology in the flow cytometric crossmatch: a multicentre study.

D. Waters, P. R. Evans, B. Shenton, 1997, Transplantation proceedings.

Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?

J. Wen, M. Gandhi, A. Bentall, 2021, Human immunology.

Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.

M. Stegall, M. Gandhi, L. Wakefield, 2017, Transplantation proceedings.

Antibody‐mediated rejection despite inhibition of terminal complement

M. Stegall, P. Dean, L. Cornell, 2014, Transplant International.